L1 Capital Pty Ltd Sells 375,815 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd sold 375,815 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $9.30, for a total value of $3,495,079.50. Following the sale, the insider owned 4,811,341 shares of the company’s stock, valued at $44,745,471.30. This trade represents a 7.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The stock was sold at an average price of $9.10, for a total transaction of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total transaction of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total transaction of $1,250,260.20.
• On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.20, for a total transaction of $4,580,790.60.
• On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total transaction of $1,906,771.23.
• On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total value of $1,688,633.79.

Anteris Technologies Global Trading Up 2.3%

AVR opened at $9.17 on Wednesday. The firm has a 50 day moving average of $9.15 and a two-hundred day moving average of $7.33. The firm has a market capitalization of $892.61 million, a PE ratio of -4.11 and a beta of 1.78. Anteris Technologies Global Corp. has a 12-month low of $3.17 and a 12-month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last issued its earnings results on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The company had revenue of $1.01 million during the quarter, compared to analysts’ expectations of $1.50 million. During the same quarter in the previous year, the company earned ($0.58) EPS. As a group, analysts predict that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Institutional Trading of Anteris Technologies Global

Several hedge funds have recently made changes to their positions in AVR. Deutsche Bank AG lifted its holdings in Anteris Technologies Global by 8.1% in the fourth quarter. Deutsche Bank AG now owns 28,865 shares of the company’s stock valued at $144,000 after acquiring an additional 2,171 shares during the last quarter. Bank of America Corp DE increased its stake in Anteris Technologies Global by 35.7% during the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after acquiring an additional 2,798 shares during the last quarter. Russell Investments Group Ltd. raised its position in Anteris Technologies Global by 76.9% in the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after purchasing an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Anteris Technologies Global by 35.2% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company’s stock valued at $45,000 after purchasing an additional 3,055 shares during the period. Finally, Barclays PLC lifted its stake in shares of Anteris Technologies Global by 3.0% in the 4th quarter. Barclays PLC now owns 148,128 shares of the company’s stock valued at $739,000 after purchasing an additional 4,289 shares during the last quarter.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Barclays upped their price objective on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, Anteris Technologies Global presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.